BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Association of Health Care Journalists - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://healthjournalism.org
X-WR-CALDESC:Events for Association of Health Care Journalists
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201026T010000
DTEND;TZID=America/New_York:20201105T010000
DTSTAMP:20260623T195000
CREATED:20231025T162233Z
LAST-MODIFIED:20231109T155000Z
UID:24383-1603674000-1604538000@healthjournalism.org
SUMMARY:PharmSci 360
DESCRIPTION:Since introducing its summer workshop\, COVID-19: Current Pharmaceutical Developments for Cures and Preventions (now available on demand)\, AAPS has made sharing the latest science on COVID-19 a priority. \nThe conversation will continue at PharmSci 360\, when scientists come together to share the latest on antiviral therapies and preventive immunizations. Registrants can dive into sessions on trial design\, modeling\, and regulatory perspectives. \nTake a moment to understand the rapidly changing landscape of COVID-19 and related coronavirus research\, as seen through the eyes of PharmSci 306’s closing plenary speakers: \n\n\nGregory Poland\, M.D.\, MACP\, FIDSA\, FRCP\, of the Mayo Clinic and Foundation\, will discuss vaccine research. \n\nRolf Hilgenfeld\, Ph.D.\, of the University of Lubeck\, Germany\, will focus on antiviral drug development. See his latest paper in Science\, “Crystal Structure of SARS-CoV-2 Main Protease Provides A Basis For Design of Improved a-Ketoamide Inhibitors.”\n\nPharmSci 360 will present 350 session as well as hundreds of posters. Register now! \n  \n 
URL:https://healthjournalism.org/event/pharmsci-360/
CATEGORIES:Event
END:VEVENT
END:VCALENDAR